Skip to main content
. Author manuscript; available in PMC: 2015 Jan 28.
Published in final edited form as: Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):841–851. doi: 10.1586/14737167.2013.852959

Table 4.

Parameter estimates in the final model (Step 2b6, Table 3) (n = 788)

Before treatment After treatment

GEN PHYS1 GEN
MENT1
GEN PHYS2 GEN
MENT2
Factor loadings (Ã)
PF1 0.783 PF2 0.783
RP1 0.772 RP2 0.772
BP1 0.678 BP2 0.678
GH1 0.787 GH2 0.787
VT1 0.783 VT2 0.783
SF1 0.388 0.433 SF2 0.388 0.433
RE1 0.729 RE2 0.729
MH1 0.782 MH2 0.782
aIntercepts (ô)
PF1 58.873 PF2 55.946
RP1 53.424 RP2 53.424
BP1 66.864 BP2 66.864
GH1 55.845 GH2 55.845
VT1 49.629 VT2 49.629
SF1 74.344 SF2 74.344
RE1 71.163 RE2 71.163
MH1 75.909 MH2 75.909
Common factor variances

GEN PHYS1 GEN
MENT1
GEN PHYS2 GEN
MENT2

1.000 1.000 1.000 1.000
Common factor correlations
GEN PHYS1 1
GEN MENT1 0.799 1
GEN PHYS2 0.831 0.668 1
GEN MENT2 0.651 0.778 0.797 1

GenPHYS: general physical health latent factor; GenMENT: general mental health latent factor; PF: physical functioning; RP: role limitations because of physical health; BP: bodily pain; SF: social functioning; MH: mental health; RE: role limitations because of emotional problems; VT: vitality; GH: general health.

Notes: (a) Bold values represent uniform recalibration response shift

1 and 2 indicates the two time points in this study, i.e., baseline and one year.